Experienced in Bladder Cancer

Gongxian Z. Wang

Jiangxi Provincial Key Laboratory Of Urinary System Diseases, 
Nanchang, CN 
Experienced in Bladder Cancer
Jiangxi Provincial Key Laboratory Of Urinary System Diseases, 
Nanchang, CN 
OverviewLocationsClinical Research

Overview

Gongxian Wang practices in Nanchang, China. Wang is rated as an Experienced expert by MediFind in the treatment of Bladder Cancer. Their top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Prostate Cancer, Lithotripsy, and Ureteroscopy.

Their clinical research consists of co-authoring 93 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of Bladder Cancer.

Locations

Jiangxi Provincial Key Laboratory Of Urinary System Diseases, Nanchang, China
Other Locations
Wuhan, 430070, China
Jiangxi, 330006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

93 Total Publications

Flexible Ureteroscopy Combined with Novel Ultra-Flexible Ureteral Access Sheaths for Treating Allium Stent Encrustation: Initial Experience with 15 Cases.
Flexible Ureteroscopy Combined with Novel Ultra-Flexible Ureteral Access Sheaths for Treating Allium Stent Encrustation: Initial Experience with 15 Cases.
Journal: Journal of endourology
Published: December 05, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile